Cancer

GRAIL Study To Evaluate Multi-Cancer Early Detection Test for Medicare Population

The study will assess the clinical impact of the Galleri test in addition to recommended cancer screenings in the Medicare population.

Cancer

Digital Morphology Solution Predicts Breast Cancer Recurrence

PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.

Cancer

Roche Expands HPV Testing for Cobas 5800 Molecular System

Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.

Roche Collaborates with Ibex, Amazon on AI-Enabled Digital Pathology Solutions for Cancer

Oct 30, 2023 | Cancer, Digital Pathology

Roche is collaborating with Ibex and AWS to enable pathology labs to access AI-powered decision support tools to support cancer diagnosis.

QIAGEN and Myriad Genetics Partner on Companion Diagnostics for Cancer

Oct 26, 2023 | Cancer, Company News

QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.

Alercell Spearheads Development of Leukemia Diagnostic Test

Oct 25, 2023 | Leukemia

Alercell’s leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.

Precede Biosciences’ Liquid Biopsy Platform Helps Inform Clinical Decision-Making

Oct 24, 2023 | Cancer, Diagnostic Technologies

The liquid biopsy platform provides resolution into the activation status of individual disease-defining genes and pathways genome-wide.

AI Tool Outperforms Other Colorectal Cancer Analysis Methods

Oct 24, 2023 | Colorectal

Researchers have developed an artificial intelligence (AI) tool for automatic colorectal cancer tissue analysis.

Blood Test Detects Tumors Early in Families with Cancer

Oct 24, 2023 | Cancer

Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.

Liquid Biopsy May Guide Colon Cancer Adjuvant Treatment

Oct 23, 2023 | Colorectal

Liquid biopsy may be used to improve the response to standard chemotherapy regimens in patients with stage III or stage II colon cancer.

Skin Cancer Diagnoses Using AI are Reliable

Oct 23, 2023 | Unknown Origin & Other Cancer Types

A research team investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from AI in a clinical scenario.

Volition Presents New Liquid Biopsy Method for Early-Stage Cancer

Oct 23, 2023 | Cancer, Molecular Diagnostics

VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.

Personalis’ MRD Assay Detects ctDNA in Lung Cancer Patients Earlier

Oct 23, 2023 | Lung Cancer, Molecular Diagnostics

NeXT Personal ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients

Thermo Fisher and Boehringer Ingelheim Sign CDx Agreement to Select NSCLC Patients for Targeted Therapy

Oct 19, 2023 | Lung Cancer

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.

Participants Named for GRAIL’s Second Multi-Cancer Screening Blood Trial

Oct 18, 2023 | Cancer

The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.

ArteraAI Validates Prognostic Model in Advanced Prostate Cancer

Oct 16, 2023 | Prostate

ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.

Universal Hereditary Cancer Genetic Testing Breast Cancer Improves Patient Outcomes

Oct 13, 2023 | Breast

Invitae announced the results of its study on universal hereditary cancer genetic testing in breast cancer patients in a rural population.

Biocartis Expands APIS Assay Technologies Collab to Commercialize Mutations Kit

Oct 12, 2023 | Breast, Molecular Diagnostics

Biocartis and APIS Assay Technologies are expanding their collaboration to include the commercialization of the APIS ESR1 Mutations Kit.

Category: Cancer

Cancer

Cancer

Cancer